Senators advocate for TRICARE to stock and cover the OTC birth control pill; double the amount of health care workers experienced workplace harassment in 2022 compared with 2018; a survey found that young adults in the United States experienced depression and anxiety twice as often as teenagers.
Read More
FluMist Quadrivalent could become the first self-administered flu vaccine in the United States; the American Society of Reproductive Medicine updates its definition of infertility to be more inclusive; the Environmental Protection Agency moves to ban the use of a cancer-causing chemical .
Read More
Medicare Advantage (MA) plans pose financial challenges for small rural hospitals; 2 bans proposed in Texas would prohibit transportation for abortion procedures; delays in reauthorizing US President's Emergency Plan for AIDS Relief (PEPFAR) risk the program’s effectiveness and integrity.
Read More
Three US senators asked the Social Security Administration to respond to a report saying it reduced or suspended benefits for those who received COVID-19 relief payments; mifepristone, a drug taken to help manage miscarriages, remains widely unavailable to patients experiencing pregnancy loss; pharmaceutical companies are beginning trials to get weight-loss shots approved for patients with obesity 6 years and older.
Read More
Monica Bertagnolli, MD, fielded questions on hot-button issues during the long-delayed Senate hearing on her nomination to head the National Institutes of Health; Pfizer announces the list price for a 5-day course of its COVID-19 antiviral, nirmatrelvir/ritonavir (Paxlovid); a federal initiative is distributing funds to programs aiming to prevent drug overdoses in pregnant women.
Read More
Medicare Part A and B premiums are set to increase by $9.80 next year; 20 experts from various specialties and institutions have developed updated brain death guidelines; many Black patients are strongly affected by multiple COVID-19 infections due to a lack of health insurance and health care access.
Read More
What We’re Reading: Alzheimer Blood Tests; Year-Long Adderall Shortage; Type 2 Diabetes Management
October 12th 2023Blood tests offer a less invasive and more accessible means of detecting Alzheimer disease; Democrats address a year-long Adderall shortage; A new study shows significantly improved clinical outcomes in Type 2 diabetes management with a digital behavioral therapy app.
Read More
What We’re Reading: Rising Breast Cancer Rates; Pharmacists Walkout; School Blood Drives on Hold
October 11th 2023Advances in treatments and early detection methods have led to improved survival rates; staffing shortages and rising demands take their toll; the US blood supply is under increasing strain.
Read More
What We’re Reading: RSV Vaccines for Pregnant Women; Medicaid Dental Care; Organ Transplant Bill
September 25th 2023The CDC recommends pregnant women receive RSV vaccinations; 6 states expand their Medicaid programs to offer dental coverage; a new bill aims to address issues in the US organ transplant system
Read More
What We’re Reading: Free COVID-19 Tests; Vaccine Distrust; FDA Rejects Epinephrine Spray
September 21st 2023The Biden administration will once again provide free COVID-19 tests for Americans; vaccine skepticism exists on both sides of the presidential race, concerning health officials; the FDA denied an application for the first nasal spray to treat allergic reactions, including anaphylaxis.
Read More